Related reading
All.Can Belgium launches new White Paper on Clinically Meaningful Endpoints
All.Can International is pleased to share the latest publication from our national initiative, All.Can Belgium. Their new white paper, “Measuring what matters: Towards a shared framework for clinically meaningful endpoints in curative oncology”, addresses a timely and complex question at the heart of modern cancer care: how can we ensure that the endpoints used in clinical trials, access pathways and decision-making truly reflect outcomes that matter to patients, clinicians and society?